AU2001235696A1 - Compositions useful for regulating parkin gene activity - Google Patents
Compositions useful for regulating parkin gene activityInfo
- Publication number
- AU2001235696A1 AU2001235696A1 AU2001235696A AU3569601A AU2001235696A1 AU 2001235696 A1 AU2001235696 A1 AU 2001235696A1 AU 2001235696 A AU2001235696 A AU 2001235696A AU 3569601 A AU3569601 A AU 3569601A AU 2001235696 A1 AU2001235696 A1 AU 2001235696A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions useful
- gene activity
- parkin gene
- regulating
- regulating parkin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
The present invention relates to novel compounds and their uses, in particular their pharmaceutical or diagnostic uses or their use as pharmacological targets. More particularly, the present invention relates to a novel protein, referred to as PAP1, as well as to novel peptides and compounds which are capable of modulating, at least partially, the activity of parkin.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0001980A FR2805266B1 (en) | 2000-02-17 | 2000-02-17 | COMPOSITIONS FOR USE IN CONTROLLING PARKIN ACTIVITY |
FR0001980 | 2000-02-17 | ||
US19848900P | 2000-04-18 | 2000-04-18 | |
US60198489 | 2000-04-18 | ||
PCT/FR2001/000461 WO2001060857A2 (en) | 2000-02-17 | 2001-02-15 | Compositions useful for regulating parkin gene activity |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001235696A1 true AU2001235696A1 (en) | 2001-08-27 |
Family
ID=26212182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001235696A Abandoned AU2001235696A1 (en) | 2000-02-17 | 2001-02-15 | Compositions useful for regulating parkin gene activity |
Country Status (14)
Country | Link |
---|---|
US (2) | US7132396B2 (en) |
EP (1) | EP1259606B1 (en) |
KR (1) | KR100811926B1 (en) |
AT (1) | ATE466083T1 (en) |
AU (1) | AU2001235696A1 (en) |
BR (1) | BR0108376A (en) |
CA (1) | CA2400256C (en) |
CY (1) | CY1111004T1 (en) |
DE (1) | DE60141948D1 (en) |
IL (3) | IL151211A0 (en) |
MX (1) | MXPA02007869A (en) |
NO (1) | NO20023914L (en) |
NZ (1) | NZ520802A (en) |
WO (1) | WO2001060857A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002357850A1 (en) * | 2001-12-14 | 2003-06-30 | Incyte Genomics, Inc. | Neurotransmission-associated proteins |
WO2004074446A2 (en) * | 2003-02-18 | 2004-09-02 | Cedars-Sinai Medical Center | Parkin interacting polypeptides and methods of use |
EP2195645B1 (en) * | 2007-09-11 | 2014-05-07 | Cancer Prevention And Cure, Ltd. | Method for aiding in the diagnosis and therapy of asthma and lung cancer |
CN109297780B (en) * | 2018-10-23 | 2021-01-01 | 东华理工大学 | Sampling method in liquid plastic limit combined determination method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2449501A (en) * | 1999-12-21 | 2001-07-03 | Incyte Genomics, Inc. | Vesicle trafficking proteins |
EP1242443A4 (en) * | 1999-12-23 | 2005-06-22 | Nuvelo Inc | Novel nucleic acids and polypeptides |
US20030220240A1 (en) * | 2000-12-21 | 2003-11-27 | Tang Y. Tom | Vesicle trafficking proteins |
-
2001
- 2001-02-15 CA CA2400256A patent/CA2400256C/en not_active Expired - Fee Related
- 2001-02-15 WO PCT/FR2001/000461 patent/WO2001060857A2/en active Application Filing
- 2001-02-15 AU AU2001235696A patent/AU2001235696A1/en not_active Abandoned
- 2001-02-15 EP EP01907820A patent/EP1259606B1/en not_active Expired - Lifetime
- 2001-02-15 NZ NZ520802A patent/NZ520802A/en not_active IP Right Cessation
- 2001-02-15 KR KR1020027010630A patent/KR100811926B1/en not_active IP Right Cessation
- 2001-02-15 MX MXPA02007869A patent/MXPA02007869A/en active IP Right Grant
- 2001-02-15 AT AT01907820T patent/ATE466083T1/en active
- 2001-02-15 IL IL15121101A patent/IL151211A0/en unknown
- 2001-02-15 DE DE60141948T patent/DE60141948D1/en not_active Expired - Lifetime
- 2001-02-15 BR BR0108376-7A patent/BR0108376A/en active Search and Examination
- 2001-02-20 US US09/785,548 patent/US7132396B2/en not_active Expired - Fee Related
-
2002
- 2002-08-12 IL IL151211A patent/IL151211A/en not_active IP Right Cessation
- 2002-08-16 NO NO20023914A patent/NO20023914L/en not_active Application Discontinuation
-
2006
- 2006-03-28 US US11/390,195 patent/US8273548B2/en not_active Expired - Fee Related
-
2008
- 2008-08-07 IL IL193310A patent/IL193310A/en not_active IP Right Cessation
-
2010
- 2010-07-27 CY CY20101100700T patent/CY1111004T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1259606B1 (en) | 2010-04-28 |
WO2001060857A2 (en) | 2001-08-23 |
US8273548B2 (en) | 2012-09-25 |
IL151211A0 (en) | 2003-04-10 |
NO20023914D0 (en) | 2002-08-16 |
ATE466083T1 (en) | 2010-05-15 |
IL193310A (en) | 2011-12-29 |
CA2400256C (en) | 2014-09-09 |
US7132396B2 (en) | 2006-11-07 |
CA2400256A1 (en) | 2001-08-23 |
CY1111004T1 (en) | 2015-06-11 |
KR100811926B1 (en) | 2008-03-10 |
DE60141948D1 (en) | 2010-06-10 |
BR0108376A (en) | 2003-03-11 |
EP1259606A2 (en) | 2002-11-27 |
US20020155577A1 (en) | 2002-10-24 |
MXPA02007869A (en) | 2003-02-10 |
IL193310A0 (en) | 2011-08-01 |
NZ520802A (en) | 2005-02-25 |
IL151211A (en) | 2010-05-31 |
NO20023914L (en) | 2002-10-11 |
KR20020089352A (en) | 2002-11-29 |
WO2001060857A3 (en) | 2002-06-20 |
US20060287230A1 (en) | 2006-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL148243A0 (en) | Trifluoromethyl sulfonyl and trifluoromethyl sulfonamido compounds and pharmaceutical compositions containing the same | |
AU3368497A (en) | Human dnase i hyperactive variants | |
CA2318398A1 (en) | Novel peptides having biological activity | |
AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
AUPP589598A0 (en) | Novel peptides | |
WO2004054607A3 (en) | Stable therapeutic proteins | |
WO1999045098A3 (en) | Delivery or proteins into eukaryotic cells with recombinant yersinia | |
AU4363199A (en) | Use of hmg proteins for the preparation of medicaments having cytotoxic activity | |
AU2002212505A1 (en) | Dna expression vectors | |
WO2001012661A3 (en) | RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-xL FUSION PROTEIN INHIBITS APOPTOSIS | |
CY1111004T1 (en) | USEFUL COMPOSITIONS FOR REGULATING PARKIN GENE ACTION | |
WO2003087353A3 (en) | Purified polypeptides involved in membrane biogenesis | |
MXPA05010575A (en) | Peptabody for cancer treatment. | |
AU7525398A (en) | Inhibitors for urokinase receptor | |
WO2003105753A3 (en) | Targeted enzymes and methods of making and using targeted enzymes. | |
AU762955C (en) | Methods and compositions useful for modulation of angiogenesis using tyrosine kinase SRC | |
AUPO089396A0 (en) | Neuroactive peptide | |
AU2002319236A1 (en) | Method for the production of protamine | |
AU2003227622A1 (en) | Methylthiophene carboxanilides | |
WO2004024765A8 (en) | Crystal structure of an angiotensin-converting enzyme (ace) and uses thereof | |
AU2001249267A1 (en) | Methods and compositions for elucidating protein expression profiles in cells | |
WO2001066709A3 (en) | Sphingomyelinase enzymes and uses relating thereto | |
AU6193699A (en) | Antisense-sequences for inhibiting the expression of the adhesion molecule icam-1 | |
WO2005105832A3 (en) | Biologically active peptide vapeehptllteaplnpk derivatives | |
WO2004020457A3 (en) | Methods and compositions for the inhibition of dna repair protein xrcc-3 |